Angiogenesis in cancer and other diseases
The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases. Concentrated efforts in this area of research are leading to the discovery of a growing number of pro- and anti-angiogenic molecules, some of which are already in clinical trials. The complex interactions among these molecules and how they affect vascular structure and function in different environments are now beginning to be elucidated. This integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases. But owing to several unanswered questions, caution is needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of vascularization is one of the landmarks of tumor environments [57,180].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [180]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundMechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 1×
“We now know there are various molecular players involved in these different mechanisms of vascular growt”
BackgroundSelf-citationAbnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Self-citationO'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · cited 1×
“However, caution is warranted as these hypoxia-inducible factors could also control cell deat”
BackgroundSelf-citationRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Self-citationCancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054 · cited 1×
“In vivo selection of phage display libraries has recently yielded peptides (for example, amino-acid sequences RGD and NGR) that preferentially recognize vessels in subcutaneous tumours in mic”
BackgroundOpenings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Self-citationHelmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Self-citation
Research works printed but not linked: 8
- Greenblatt, M. & Shubik, P. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparant chamber technique. J. Natl Cancer Inst. 41, 111–124 (1968).
- Ehrmann, R. L. & Knoth, M. Choriocarcinoma: transfilter stimulation of vasoproliferation in the hamster cheek pouch studied by light and electron microscopy. J. Natl Cancer Inst. 41, 1329 –1341 (1968).
- Folkman, J. in Cancer Medicine (eds Holland, J. F. et al.) 132– 152 (Decker, Ontario, Canada, 2000).
- Chang, Y. S. et al. Abundance of neoplastic cells in vessel walls of human tumor xenografts. Proc. Am. Assoc. Cancer Res. (in the press).
- Seljelid, R., Jozefowski, S. & Sveinbjornsson, B. Tumor stroma. Anticancer Res. 19, 4809–4822 (1999).
- Buschmann, I. & Schaper, W. The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190, 338–342 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<338::aid-path594>3.0.co;2-7
- Carmeliet, P. & Collen, D. Transgenic mouse models in angiogenesis and cardiovascular disease. J. Pathol. 190, 387–405 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<387::aid-path595>3.0.co;2-r
- Tsuzuki, Y. et al. VEGF modulation by targeting HIF-1alpha/HRE/VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. (in the press).
Cited by
Items 601–700 of 1,084
Advancing animal models of neoplasia through in vivo bioluminescence imaging
Edinger, M., Cao, Y.-A., Hornig, Y. S., Jenkins, D. E., Verneris, M. R., Bachmann, M. H., Negrin, R. S., & Contag, C. H. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00410-0 · Cited by 226
“The ability to detect the dynamics of tumour stasis and necrosis in vivo should also facilitate studies of angiogenesis inhibitors which are currently being evaluated in preclinical tumour models as well as in clinical trials [21].”
BackgroundAdaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
Wu, P., Gao, W., Su, M., Nice, E. C., Zhang, W., Lin, J., & Xie, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641469 · Cited by 209
“Accordingly, blood flow in tumors becomes chaotic and variable (Carmeliet and Jain, 2000).”
BackgroundIntussusceptive angiogenesis––the alternative to capillary sprouting
Burri, P. H., & Djonov, V. (2002) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(02)00096-1 · Cited by 209
Yang, Y., Liu, X., Ma, W., Xu, Q., Chen, G., Wang, Y., Xiao, H., Li, N., Liang, X.-J., Yu, M., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120456 · Cited by 209
Zhu, N., Zhang, D., Xie, H., Zhou, Z., Chen, H., Hu, T., Bai, Y., Shen, Y., Yuan, W., Jing, Q., et al. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0723-7 · Cited by 206
“Moreover, it is one of the major cytokines involved in tumor angiogenesis [3].”
BackgroundEriksson, A., Cao, R., Pawliuk, R., Berg, S.-M., Tsang, M., Zhou, D., Fleet, C., Tritsaris, K., Dissing, S., Leboulch, P., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00028-4 · Cited by 198
Lactate dehydrogenase: a marker of diminished antitumor immunity
Van Wilpe, S., Koornstra, R., Den Brok, M., De Groot, J. W., Blank, C., De Vries, J., Gerritsen, W., & Mehra, N. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1731942 · Cited by 208
“However, the imbalance between pro- and antiangiogenic factors commonly leads to a highly disorganized and dysfunctional tumor vasculature.(30) Therefore, angiogenesis does”
BackgroundMethylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis
Kim, Y., Nam, H. J., Lee, J., Park, D. Y., Kim, C., Yu, Y. S., Kim, D., Park, S. W., Bhin, J., Hwang, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms10347 · Cited by 208
Wu, F. T. H., Stefanini, M. O., Gabhann, F. M., Kontos, C. D., Annex, B. H., & Popel, A. S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00941.x · Cited by 203
“In the category of anti-angiogenic therapy, a prime research focus has been on the development of angiogenesis inhibitors as anti-cancer drugs, including the FDA-approved bevacizumab (a humanized monoclonal antibody against VEGF), sorafenib and sunitinib (receptor tyrosine kinase inhibitors) [9]; many others still in…”
BackgroundAngiogenesis in Wounds Treated by Microdeformational Wound Therapy
Erba, P., Ogawa, R., Ackermann, M., Adini, A., Miele, L. F., Dastouri, P., Helm, D., Mentzer, S. J., D’Amato, R. J., Murphy, G. F., et al. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31820563a8 · Cited by 207
Manipulating angiogenesis in medicine
Carmeliet, P. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2003.01297.x · Cited by 207
Self-citationDatta, M., Via, L. E., Kamoun, W. S., Liu, C., Chen, W., Seano, G., Weiner, D. M., Schimel, D., England, K., Martin, J. D., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424563112 · Cited by 207
“Hypoxia is known to increase production of proangiogenic cytokines, including VEGF, in solid tumors (19).”
BackgroundSelf-citationCombinations of Bevacizumab With Cancer Immunotherapy
Chen, D. S., & Hurwitz, H. (2018) · The Cancer Journal · doi:10.1097/ppo.0000000000000327 · Cited by 207
Angiogenic factors as potential drug target: Efficacy and limitations of anti-angiogenic therapy
Gacche, R. N., & Meshram, R. J. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.05.002 · Cited by 193
“sides the observations that tumors harbor heavy angiogenesis around themselves, was described nearly 100 years ago [46].”
BackgroundKiessling, F., Greschus, S., Lichy, M. P., Bock, M., Fink, C., Vosseler, S., Moll, J., Mueller, M. M., Fusenig, N. E., Traupe, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1101 · Cited by 205
“Experimental and clinical studies have demonstrated the impact of angiogenesis on the development of cancer and other disease”
BackgroundLijnen, H. R. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm007 · Cited by 206
Natural mechanisms protecting against cancer
Jakóbisiak, M., Lasek, W., & Gołąb, J. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.08.005 · Cited by 206
Matrix metalloproteinases: their functional role in lung cancer
Merchant, N., Nagaraju, G. P., Rajitha, B., Lammata, S., Jella, K. K., Buchwald, Z. S., Lakka, S. S., & Ali, A. N. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx063 · Cited by 206
Cyclooxygenase-2: a therapeutic target in angiogenesis
Iñiguez, M. A., Rodrı́guez, A., Volpert, O. V., Fresno, M., & Redondo, J. M. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)00011-4 · Cited by 206
Roles of VEGF-A signalling in development, regeneration, and tumours
Matsumoto, K., & Ema, M. (2014) · Journal of Biochemistry · doi:10.1093/jb/mvu031 · Cited by 198
Cardiovascular tissue engineering
Rabkin, E., & Schoen, F. J. (2002) · Cardiovascular Pathology · doi:10.1016/s1054-8807(02)00130-8 · Cited by 200
“Owing to the limited capacity of oxygen to diffuse over distances in excess of 100–200 mm in tissues, a system of perfusion is necessary for tissues of macroscopic dimensions [102].”
BackgroundCliment, M., Quintavalle, M., Miragoli, M., Chen, J., Condorelli, G., & Elia, L. (2015) · Circulation Research · doi:10.1161/circresaha.116.305178 · Cited by 203
Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment
Hanna, A., & Shevde, L. A. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0509-3 · Cited by 205
“Both VEGF and FGF are direct transcriptional targets of the Hh signaling pathway [89].”
BackgroundBao, L., You, B., Shi, S., Shan, Y., Zhang, Q., Yue, H., Zhang, J., Zhang, W., Shi, Y., Liu, Y., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0183-6 · Cited by 206
“It involves sophisticated orchestration of endothelial cells (ECs) activities, including proliferation, migration, invasion, adhesion, and differentiation [8, 9].”
BackgroundLUTTUN, A., TJWA, M., & CARMELIET, P. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04870.x · Cited by 202
Self-citationCancer prevention and screening: the next step in the era of precision medicine
Loomans-Kropp, H. A., & Umar, A. (2019) · npj Precision Oncology · doi:10.1038/s41698-018-0075-9 · Cited by 205
“Models of pancreatic cancer have demonstrated the necessity of fibroblasts in tumor cell propagation, while additional carcinogenesis models have shown that recruitment of endothelial cells to the tumor is necessary for growth beyond 1–2mm(3).(27,28) Cancer progresses in spatial and temporal domains, where it may take…”
BackgroundContact-Inhibited Chemotaxis in De Novo and Sprouting Blood-Vessel Growth
Merks, R. M. H., Perryn, E. D., Shirinifard, A., & Glazier, J. A. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000163 · Cited by 205
“phenomena in healthy and diseased individuals, including wound healing and tumor growth [1,2].”
BackgroundDissanayaka, W. L., Hargreaves, K. M., Jin, L., Samaranayake, L. P., & Zhang, C. (2015) · Tissue Engineering Part A · doi:10.1089/ten.tea.2014.0154 · Cited by 194
Proteomic Analysis of Microvesicles Derived from Human Colorectal Cancer Cells
Choi, D.-S., Lee, J.-M., Park, G. W., Lim, H.-W., Bang, J. Y., Kim, Y.-K., Kwon, K.-H., Kwon, H. J., Kim, K. P., & Gho, Y. S. (2007) · Journal of Proteome Research · doi:10.1021/pr070192y · Cited by 200
Lymphangiogenesis and tumor metastasis
Pepper, M. S., Tille, J.-C., Nisato, R., & Skobe, M. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0748-7 · Cited by 198
“Finally, the prevailing view has been that lymphatic vessels are absent from tumors and that lymphangiogenesis does not occur in cancer (Carmeliet and Jain 2000; Jain and Padera 2002; Leu et al. 2000).”
BackgroundSerial noninvasive photoacoustic imaging of neovascularization in tumor angiogenesis
Siphanto, R. I., Thumma, K. K., Kolkman, R. G. M., van Leeuwen, T. G., de Mul, F. F. M., van Neck, J. W., van Adrichem, L. N. A., & Steenbergen, W. (2005) · Optics Express · doi:10.1364/opex.13.000089 · Cited by 205
Koh, W., Mahan, R. D., & Davis, G. E. (2008) · Journal of Cell Science · doi:10.1242/jcs.020693 · Cited by 195
“These events are controlled by key molecules, including integrins, extracellular matrices, proteases and growth factors (Carmeliet and Jain, 2000; Davis and Bayless, 2003; Davis et al., 2002; Hanahan, 1997; Kuwano et al., 2001; Saunders et al., 2006).”
BackgroundBussolati, B., Ahmed, A., Pemberton, H., Landis, R. C., Di Carlo, F., Haskard, D. O., & Mason, J. C. (2004) · Blood · doi:10.1182/blood-2003-06-1974 · Cited by 199
Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery
Davodabadi, F., Sajjadi, S. F., Sarhadi, M., Mirghasemi, S., Nadali Hezaveh, M., Khosravi, S., Kamali Andani, M., Cordani, M., Basiri, M., & Ghavami, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176013 · Cited by 184
Circulating endothelial progenitor cells in multiple myeloma: implications and significance
Zhang, H. (2005) · Blood · doi:10.1182/blood-2004-06-2101 · Cited by 205
Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability
Odorisio, T., Schietroma, C., Zaccaria, M. L., Cianfarani, F., Tiveron, C., Tatangelo, L., Failla, C. M., & Zambruno, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.12.2559 · Cited by 203
Maharaj, A. S. R., & D'Amore, P. A. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.03.004 · Cited by 195
“VEGF is also upregulated and involved in pathophysiologic processes such as in rheumatoid arthritis [25, 26], psoriasis [27], atherosclerosis [28], amyloid lateral sclerosis (ALS) [29], age-related macular degeneration (AMD) [30,31], diabetic retinopathy [32,33], retinopathy of prematurity [34], sepsis [35] and tumor…”
Backgrounddi Tomaso, E., Snuderl, M., Kamoun, W. S., Duda, D. G., Auluck, P. K., Fazlollahi, L., Andronesi, O. C., Frosch, M. P., Wen, P. Y., Plotkin, S. R., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2602 · Cited by 199
Self-citationHydrogels with precisely controlled integrin activation dictate vascular patterning and permeability
Li, S., Nih, L. R., Bachman, H., Fei, P., Li, Y., Nam, E., Dimatteo, R., Carmichael, S. T., Barker, T. H., & Segura, T. (2017) · Nature Materials · doi:10.1038/nmat4954 · Cited by 202
Type IV collagen-derived angiogenesis inhibitors
Mundel, T. M., & Kalluri, R. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.05.005 · Cited by 194
“The “angiogenic switch” is likely turned “On” in several diseases such as psoriasis, rheumatoid arthritis, diabetic retinopathy, and cancer (Augustin, 2003; Carmeliet, 2003; Carmeliet and Jain, 2000; Folkman and Kalluri, 2003).”
BackgroundInfluentialSexual Dimorphism in Colon Cancer
Abancens, M., Bustos, V., Harvey, H., McBryan, J., & Harvey, B. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.607909 · Cited by 176
Chelvanambi, M., Fecek, R. J., Taylor, J. L., & Storkus, W. J. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001906 · Cited by 201
The breast tumor microenvironment: role in cancer development, progression and response to therapy
Mittal, S., Brown, N. J., & Holen, I. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1439382 · Cited by 201
“Endothelial cells, which form the lining of tumor blood vessels, are a major component of the tumor microenvironment stromal compartment and are central to the process of tumor angiogenesis [75].”
BackgroundOptical Systems for in Vivo Molecular Imaging of Cancer
Sokolov, K., Aaron, J., Hsu, B., Nida, D., Gillenwater, A., Follen, M., MacAulay, C., Adler-Storthz, K., Korgel, B., Descour, M., et al. (2003) · Technology in Cancer Research & Treatment · doi:10.1177/153303460300200602 · Cited by 203
Bioavailability of VEGF in Tumor-Shed Vesicles Depends on Vesicle Burst Induced by Acidic pH
Taraboletti, G., D'Ascenzoy, S., Giusti, I., Marchetti, D., Borsotti, P., Millimaggi, D., Giavazzi, R., Pavan, A., & Dolo, V. (2006) · Neoplasia · doi:10.1593/neo.05583 · Cited by 199
Perfused 3D angiogenic sprouting in a high-throughput in vitro platform
van Duinen, V., Zhu, D., Ramakers, C., van Zonneveld, A. J., Vulto, P., & Hankemeier, T. (2019) · Angiogenesis · doi:10.1007/s10456-018-9647-0 · Cited by 199
Zhang, L., Su, H., Cai, J., Cheng, D., Ma, Y., Zhang, J., Zhou, C., Liu, S., Shi, H., Zhang, Y., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b06267 · Cited by 199
Wang, T., Ward, Y., Tian, L., Lake, R., Guedez, L., Stetler-Stevenson, W. G., & Kelly, K. (2005) · Blood · doi:10.1182/blood-2004-07-2878 · Cited by 192
Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia
Li, L., ten Hagen, T. L. M., Bolkestein, M., Gasselhuber, A., Yatvin, J., van Rhoon, G. C., Eggermont, A. M. M., Haemmerich, D., & Koning, G. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.026 · Cited by 195
“Tumor vasculature manipulation provides a mode to improve anticancer drug delivery [1–3].”
BackgroundBrain tumor stem cells: Molecular characteristics and their impact on therapy
Schonberg, D. L., Lubelski, D., Miller, T. E., & Rich, J. N. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.06.004 · Cited by 198
“Hypoxia and GSCs 4.1 Hypoxia signaling Tumor-mediated recruitment or at least attraction of vasculature acts a neoplastic feeding source yet often vessels are highly disorganized and diffuse of oxygen likely due to rapid tumor expansion (Carmeliet and Jain, 2000).”
BackgroundInfluentialTaga, T., Suzuki, A., Gonzalez‐Gomez, I., Gilles, F. H., Stins, M., Shimada, H., Barsky, L., Weinberg, K. I., & Laug, W. E. (2002) · International Journal of Cancer · doi:10.1002/ijc.10265 · Cited by 198
Li, F., Zhang, J., Arfuso, F., Chinnathambi, A., Zayed, M. E., Alharbi, S. A., Kumar, A. P., Ahn, K. S., & Sethi, G. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1470-4 · Cited by 198
“This process is initiated by an “angiogenic switch” in which the balance between pro-angiogenic and anti-angiogenic factors is tipped toward angiogenesis (Carmeliet and Jain 2000).”
BackgroundSchäfer, G., Cramer, T., Suske, G., Kemmner, W., Wiedenmann, B., & Höcker, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211999200 · Cited by 198
Pereira, E. R., Frudd, K., Awad, W., & Hendershot, L. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.507194 · Cited by 191
“When cells experience inadequate oxygen or nutrients because of limitations in their blood supply, signal transduction pathways are activated, leading to the secretion of factors that induce the production of new blood vessels from surrounding endothelial cells in a process known as angiogenesis (1, 2).”
BackgroundKong, D., Li, Y., Wang, Z., Banerjee, S., & Sarkar, F. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4277 · Cited by 195
“The growth and metastasis of prostate cancer and other tumors is dependent on the induction of new blood vessels from preexisting ones through angiogenesis ( 1 ).”
RetractedGerber, S. A., Rybalko, V. Y., Bigelow, C. E., Lugade, A. A., Foster, T. H., Frelinger, J. G., & Lord, E. M. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051222 · Cited by 197
“Only small groups of immune cells remained on day 6 along with evidence of sprouting and webbed vessels indicative of angiogenesis (arrowheads).(31,32) By day 8, tumor growth had completely displaced most of the immune cells except for sporadic CD45 cells found within the tumor mass, which are possibly remnants of the…”
Beyond matrix stiffness: targeting force-induced cancer drug resistance
Kalli, M., Poskus, M. D., Stylianopoulos, T., & Zervantonakis, I. K. (2023) · Trends in Cancer · doi:10.1016/j.trecan.2023.07.006 · Cited by 167
“In turn, this results in uniformly elevated IFP , washing drugs out of the tumor [12,13].”
BackgroundBray, L. J., Binner, M., Holzheu, A., Friedrichs, J., Freudenberg, U., Hutmacher, D. W., & Werner, C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.124 · Cited by 197
Ulbrich, W., & Lamprecht, A. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0285.focus · Cited by 197
Padró, T., Bieker, R., Ruiz, S., Steins, M., Retzlaff, S., Bürger, H., Büchner, T., Kessler, T., Herrera, F., Kienast, J., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402534 · Cited by 197
Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis
Emdad, L., Lee, S.-G., Su, Z. Z., Jeon, H. Y., Boukerche, H., Sarkar, D., & Fisher, P. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910936106 · Cited by 194
“, angiogenesis, to sustain the growth of the primary and secondary metastatic tumors (32, 33).”
BackgroundJeong, J. M., Hong, M. K., Chang, Y. S., Lee, Y., Kim, Y. J., Cheon, G. J., Lee, D. S., Chung, J., & Lee, M. C. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047423 · Cited by 197
“Angiogenesis is related to various diseases, such as cancer, arthritis, and psoriasis (1).”
BackgroundThe multifaceted role of mesenchymal stem cells in cancer
Timaner, M., Tsai, K. K., & Shaked, Y. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.003 · Cited by 193
Kamei, K.-I., Mashimo, Y., Koyama, Y., Fockenberg, C., Nakashima, M., Nakajima, M., Li, J., & Chen, Y. (2015) · Biomedical Microdevices · doi:10.1007/s10544-015-9928-y · Cited by 196
A three-dimensional in vitro model of tumor cell intravasation
Ehsan, S. M., Welch-Reardon, K. M., Waterman, M. L., Hughes, C. C. W., & George, S. C. (2014) · Integrative Biology · doi:10.1039/c3ib40170g · Cited by 196
Endothelial cells and the IGF system
Bach, L. A. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0215 · Cited by 196
The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
Klein, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00367 · Cited by 196
The TGF-β Paradox in Human Cancer: An Update
Tian, M., & Schiemann, W. P. (2009) · Future Oncology · doi:10.2217/14796694.5.2.259 · Cited by 196
“TGF‐β & endothelial cells Angiogenesis is the process whereby new blood vessels sprout and form from preexisting vessels; it also is an essential physiological process that transpires during embryonic development, wound healing and the female reproductive cycle [55,56].”
BackgroundLi, J., Zhang, Y., Liu, Y., Dai, X., Li, W., Cai, X., Yin, Y., Wang, Q., Xue, Y., Wang, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.489302 · Cited by 196
“For example, in addition to being the most effective mechanism to overcome the lack of nutrients and oxygen and to remove waste products from a growing tumor, angiogenesis provides the principal route by which tumor cells exit the primary tumor site and enter the circulation (2, 3).”
BackgroundCheca, S., & Prendergast, P. J. (2009) · Annals of Biomedical Engineering · doi:10.1007/s10439-008-9594-9 · Cited by 194
Molecular responses to hypoxia in tumor cells.
Kunz, M., & Ibrahim, S. M. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-23 · Cited by 224
“A large series of clinical trials are currently underway testing various antiangiogenic compounds for their efficacy in tumor therapy [for review, see [55]].”
BackgroundMethodInfluentialAngiogenesis in prostate cancer: onset, progression and imaging
Russo, G., Mischi, M., Scheepens, W., De la Rosette, J. J., & Wijkstra, H. (2012) · BJU International · doi:10.1111/j.1464-410x.2012.11444.x · Cited by 195
p53-Mediated Inhibition of Angiogenesis Through Up-Regulation of a Collagen Prolyl Hydroxylase
Teodoro, J. G., Parker, A. E., Zhu, X., & Green, M. R. (2006) · Science · doi:10.1126/science.1126391 · Cited by 195
Li, Y., Wu, Z., Yuan, J., Sun, L., Lin, L., Huang, N., Bin, J., Liao, Y., & Liao, W. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.035 · Cited by 195
Koh, W., Stratman, A. N., Sacharidou, A., & Davis, G. E. (2008) · Methods in Enzymology · doi:10.1016/s0076-6879(08)02005-3 · Cited by 195
Nawaz, I. M., Rezzola, S., Cancarini, A., Russo, A., Costagliola, C., Semeraro, F., & Presta, M. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.03.002 · Cited by 195
Ultrasmall Near‐Infrared Non‐cadmium Quantum Dots for in vivo Tumor Imaging
Gao, J., Chen, K., Xie, R., Xie, J., Lee, S., Cheng, Z., Peng, X., & Chen, X. (2010) · Small · doi:10.1002/smll.200901672 · Cited by 194
Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer
Kamat, A. A., Merritt, W. M., Coffey, D., Lin, Y. G., Patel, P. R., Broaddus, R., Nugent, E., Han, L. Y., Landen, C. N., Spannuth, W. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1017 · Cited by 192
Humphrey, J. S., Price, K., Gupta, E., Baxter, A., Bird, J., Sonnichsen, D., & Naglich, J. (2003) · Chemoradiation in Cancer Therapy · doi:10.1007/978-1-59259-325-5_21 · Cited by 193
Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms
Kaushik, N., Borkar, S. B., Nandanwar, S. K., Panda, P. K., Choi, E. H., & Kaushik, N. K. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01364-2 · Cited by 179
Matricellular proteins in the heart: possible role during stress and remodeling
SCHELLINGS, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.06.006 · Cited by 194
Li, Y., Zhang, F., Nagai, N., Tang, Z., Zhang, S., Scotney, P., Lennartsson, J., Zhu, C., Qu, Y., Fang, C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33673 · Cited by 194
Silk fibroin/chondroitin sulfate/hyaluronic acid ternary scaffolds for dermal tissue reconstruction
Yan, S., Zhang, Q., Wang, J., Liu, Y., Lu, S., Li, M., & Kaplan, D. L. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.02.016 · Cited by 194
Magnetic iron oxide nanoparticles for disease detection and therapy
Tong, S., Zhu, H., & Bao, G. (2019) · Materials Today · doi:10.1016/j.mattod.2019.06.003 · Cited by 190
Schindler, R., & Mentlein, R. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1477 · Cited by 193
Bondjers, C., He, L., Takemoto, M., Norlin, J., Asker, N., Hellström, M., Lindahl, P., Betsholtz, C., Bondjers, C., He, L., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4944fje · Cited by 193
“Angiogenesis, the collective term for the sprouting, splitting, growth, and remodeling of blood vessels, is a central process in vertebrate embryonic development as well as in many pathological conditions such as chronic inflammation, diabetes complications, and cancer (1, 2).”
BackgroundThe pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge
Cavallaro, G., Filippi, L., Bagnoli, P., La Marca, G., Cristofori, G., Raffaeli, G., Padrini, L., Araimo, G., Fumagalli, M., Groppo, M., et al. (2014) · Acta Ophthalmologica · doi:10.1111/aos.12049 · Cited by 193
Nagl, L., Horvath, L., Pircher, A., & Wolf, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00766 · Cited by 180
“VEGF superfamily central angiogenic factors of tumor angiogenesis (Carmeliet and Jain, 2000; Potente et al., 2011).”
BackgroundInfluentialMesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines
Liang, W., Chen, X., Zhang, S., Fang, J., Chen, M., Xu, Y., & Chen, X. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00246-5 · Cited by 180
“Fast maturation and expansion of the tumor vasculature is essential to satisfy the high requirement for nutrients and oxygen in primary metastatic sites and tumors [120].”
BackgroundPoly(vinyl alcohol) gels for use as tissue phantoms in photoacoustic mammography
Kharine, A., Manohar, S., Seeton, R., Kolkman, R. G. M., Bolt, R. A., Steenbergen, W., & Mul, F. F. M. D. (2003) · Physics in Medicine and Biology · doi:10.1088/0031-9155/48/3/306 · Cited by 193
“When illuminated with pulsed laser light, a tumour site by virtue of its higher absorption with respect to th eh ealthy background tissue, due to angiogenesis ( Carmeliet and Jain 2000 ), will act as a source of bipolar photoacoustic pulses (Oraevsky et al 2002, and references therein).”
BackgroundComplex mechanics of the heterogeneous extracellular matrix in cancer
Malandrino, A., Mak, M., Kamm, R. D., & Moeendarbary, E. (2018) · Extreme Mechanics Letters · doi:10.1016/j.eml.2018.02.003 · Cited by 192
“Some of these interactions are being targeted actively in therapeutic development, such as angiogenesis, MMPs, and chronic inflammation [5,63], whereas other factors such as mechanical interactions and force generation, which are also important in normal tissuemaintenance and function,may require novel strategies.”
BackgroundGe, R., Wang, Z., & Cheng, L. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00272-w · Cited by 192
The advantages of co-culture over mono cell culture in simulating in vivo environment
Miki, Y., Ono, K., Hata, S., Suzuki, T., Kumamoto, H., & Sasano, H. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.12.004 · Cited by 192
d’Onofrio, A., & Gandolfi, A. (2004) · Mathematical Biosciences · doi:10.1016/j.mbs.2004.06.003 · Cited by 192
Structural Adaptation and Heterogeneity of Normal and Tumor Microvascular Networks
Pries, A. R., Cornelissen, A. J. M., Sloot, A. A., Hinkeldey, M., Dreher, M. R., Höpfner, M., Dewhirst, M. W., & Secomb, T. W. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000394 · Cited by 192
“By contrast, the walls of tumor microvessels in general do not exhibit a regular composition with endothelial cells, basement membrane and smooth muscle layer [39,40].”
BackgroundPollack, I. F., Jakacki, R. I., Blaney, S. M., Hancock, M. L., Kieran, M. W., Phillips, P., Kun, L. E., Friedman, H., Packer, R., Banerjee, A., et al. (2007) · Neuro-Oncology · doi:10.1215/15228517-2006-031 · Cited by 192
“The mechanism for such an effect, if any, is conjectural and may reflect the impact of PDGFR inhibition on endothelial cell function (Carmeliet and Jain, 2000; Jensen, 1998; Pietras et al., 2001; Wang et al., 1999) rather than a direct effect on the tumor cells themselves.”
BackgroundWu, Y., Hooper, A. T., Zhong, Z., Witte, L., Bohlen, P., Rafii, S., & Hicklin, D. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.21865 · Cited by 192
“VEGF-A is a multifunctional cytokine, which is a central regulator of physiological and pathological angiogenesis.(5,6) VEGF-A”
BackgroundCianfrocca, M. E., Kimmel, K. A., Gallo, J., Cardoso, T., Brown, M. M., Hudes, G., Lewis, N., Weiner, L., Lam, G. N., Brown, S. C., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603171 · Cited by 184
“…www.bjcancer.com Published online 16 May 2006 & 2006 Cancer Research UK Keywords: ATN-161; a5b1 integrin; avb3 integrin; phase 1 trial; angiogenesis Angiogenesis is a requirement for the growth of nearly all tumours and most metastases (Folkman, 1995; Carmeliet and Jain, 2000).”
Review of optical breast imaging and spectroscopy
Grosenick, D., Rinneberg, H., Cubeddu, R., & Taroni, P. (2016) · Journal of Biomedical Optics · doi:10.1117/1.jbo.21.9.091311 · Cited by 187
“, to plasma proteins such as albumin.(18,30) Generally,”
BackgroundExosomes from HNSCC Promote Angiogenesis through Reprogramming of Endothelial Cells
Ludwig, N., Yerneni, S. S., Razzo, B. M., & Whiteside, T. L. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0358 · Cited by 187
“For solid tumors, an adequate blood supply is of critical importance for the development, growth, and metastasis (21).”
Background
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- Harvard University (US)
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2000-09
- Volume
- 407
- Issue
- 6801
- Pages
- 249-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1573363574
- Cited by
- 9,070
- References
- 72
- Citations by year
- 2026: 166 · 2025: 208 · 2024: 246 · 2023: 330 · 2022: 335 · 2021: 381 · 2020: 368 · 2019: 349 · 2018: 375 · 2017: 380 · 2016: 378 · 2015: 364 · 2014: 414 · 2013: 412 · 2012: 416
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- pathological angiogenesis, cancer, ischemic diseases, inflammatory diseases, anti-angiogenic therapy, clinical trials
- MeSH terms
- Animals, Disease, Humans, Lymphokines, Neoplasms, Neovascularization, Pathologic, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.